Precision Biosystems is Massachusetts based company that provides instrumental solution to the difficult problems of laboratory automation. Precision Biosystems is a developer and manufacturer of a BlotCycler, an automated western blot processor, based on patented fluid distribution technology. All steps after protein transfer to a membrane are fully automated: shaking, blocking, hybridization, washing, and recycling of primary antibody. BlotCycler offers unique advantages over existing technologies in using immunoblotting for research and clinical work. Unique fluidic-based washing technology allows significant increase in sensitivity and requires less antibodies. The introduction of BlotCycler made consistent, reproducible, and high quality western blot a reality. Check our website: http://precisionbiosystems.com/freetrial/
Pluto Bio
Pluto Bio is the translational alignment platform for drug discovery teams working with complex multi-omic evidence. Pluto helps scientists analyse, interpret, and connect biological evidence across targets, models, mechanisms, and disease context. Instead of rebuilding the scientific story from scattered tools, slides, and reviews, teams can see what is supported, missing, or conflicted directly inside the work. Powered by the Translational Alignment Framework™, Pluto makes program-level biological truth visible so teams can move from fragmented analysis to clearer translational confidence. Visit Pluto Bio at Booth 4513 at AACR 2026.
Plasmidsaurus
Plasmidsaurus, headquartered in South San Francisco, is the global leader in DNA Sequencing as a Service. Founded at Caltech in 2021, the company has rapidly scaled to a valuation nearing $1B, with 10 laboratories worldwide, including facilities in London, Germany, and Singapore. Plasmidsaurus’ portfolio features the world’s fastest RNA-seq, pioneering whole plasmid sequencing, comprehensive genome and microbiome analysis, and advanced viral vector sequencing. Delivered with unmatched speed, accuracy, and decision-ready insights, these services are powered by a dominant bioinformatics platform. Plasmidsaurus’ mission is to make sequencing as accessible, dependable, and transformative as digital infrastructure, redefining the future of genetic discovery.
Picopoint Genomics
Picopoint Genomics provides a revolutionary spatial RNA sequencing service that is compatible with tiny regions of interest from archival formalin-fixed paraffin-embedded (FFPE) tissue. Unlike broad and shallow platforms that capture a wide swathe of tissue but produce low-complexity data, our focused and deep RNA-seq platform specifically captures your regions of interest and sequences all mRNA genes, of any species, producing bulk-quality data for powerful gene-expression analysis. Our platform is robust to archival samples that fail on other platforms and has succeeded with FFPE blocks over 20 years old, which means you can conduct retrospective studies on cases whose outcomes are already known. Less than 0.1 mm2 of tissue is required from a single 7 µm slide section, allowing you to capture and compare pure cell clusters. Our competitive pricing allows you to scale up your studies to cohorts with hundreds of subjects. With our full-service workflow from tissue to bioinformatics, including clinical trial analysis and biomarker development, you won’t need freshly preserved tissue samples or a team of lab technicians and bioinformaticians to complete your next project!
Parse Biosciences
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. Founded based on a transformative technology invented at the University of Washington, Parse is used by over 1,000 labs across the world. Our growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, GigaLab, and a software tool for data analysis. | Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
PamGene Int. – KinomePro
PamGene offers high-throughput kinase activity profiling, delivering critical insights into cell signaling pathways. Our technology screens multiple (cellular) kinases simultaneously, helping you understand disease mechanisms, drug effects, and resistance, and supporting translational research. Key Applications: Cancer Research: Identify new therapeutic targets and uncover resistance mechanisms to improve treatment strategies. Drug Development: Evaluate small molecule selectivity to develop more effective, targeted therapies. Biomarker Discovery: Detect kinase activity patterns that predict patient responses, enabling personalized and translational treatments. Our powerful platform also supports the development of diagnostics, including the IOpener™ diagnostic test, which predicts patient responses to immune checkpoint inhibitors like CTLA-4 and PD1. This biomarker assay approach can be applied to create other predictive diagnostics for translational research. Comprehensive Reporting: We provide detailed reports for every project, offering clear analysis, visualizations, and actionable insights, so you have all the data needed for informed decision-making. Partner with PamGene to advance your translational research and improve clinical outcomes through a deeper understanding of cellular processes.
PacBio
PacBio is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. | PacBio is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. PacBio products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our SBB® short read sequencing technologies. PacBio products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
OZ BIOSCIENCES
OZ Biosciences creates, develops and produces innovative molecular delivery systems specialized in transfection reagents (Magnetofection, Lipofection, Polyfection) and transduction tools (viral enhancers), mRNA (catalog and custom service), LNP: Lipid nanoparticles formulation (catalog and custom service), PNPs, adjuvants, bioproduction reagents (virus and protein production) and assay kits, for the worldwide scientific community and pharmaceutical industry. OZ Biosciences is focused on delivery technologies of biomolecules such as DNA, RNA and proteins for in vitro and in vivo applications.
Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural aberrations. | Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. With real-time, multiomic nanopore sequencing, you can discover previously hidden human genomic, epigenomic, and transcriptomic variation — from the population to the single-cell level.
OMICS EMPOWER
Empowering Research with Multi-Omics Innovations We provide multi-omics technical services for life science research, including comprehensive products such as single-cell sequencing, spatial omics and bioinformatics analysis. We are committed to enhancing life through technology and benefiting humanity through scientific innovation.